MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+14.36%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.63B
AUM Growth
+$146M
(+9.9%)
Cap. Flow
+$5.33M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
44.09%
Holding
1,031
New
130
Increased
362
Reduced
254
Closed
185
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$65.8M |
| 2 |
Ametek
AME
|
+$14.2M |
| 3 |
General Dynamics
GD
|
+$13.3M |
| 4 |
Morningstar
MORN
|
+$12.8M |
| 5 |
Capital One
COF
|
+$12.7M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$68.6M |
| 2 |
Apple
AAPL
|
+$35.2M |
| 3 |
Dover
DOV
|
+$18.2M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$12.9M |
| 5 |
Microsoft
MSFT
|
+$12.7M |
Sector Composition
| 1 | Technology | 25.9% |
| 2 | Financials | 17.27% |
| 3 | Communication Services | 9.63% |
| 4 | Industrials | 9.11% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNH
801
CNH Industrial
CNH
$14.2B
| $2.48K | ﹤0.01% |
191
-312
| -62% | -$4.04K |
|
802
Core & Main
CNM
$9.43B
| $2.47K | ﹤0.01% |
41
-58
| -59% | -$3.5K |
|
803
Guardant Health
GH
$7.41B
| $2.39K | ﹤0.01% |
46
+2
| +5% | +$104 |
|
804
Fortune Brands Innovations
FBIN
$7.05B
| $2.37K | ﹤0.01% |
+46
| New | +$2.37K |
|
|
BPMC
805
DELISTED
Blueprint Medicines
BPMC
| $2.31K | ﹤0.01% |
+18
| New | +$2.31K |
|
806
Golar LNG
GLNG
$4.23B
| $2.31K | ﹤0.01% |
+56
| New | +$2.31K |
|
807
Elanco Animal Health
ELAN
$9.32B
| $2.29K | ﹤0.01% |
+160
| New | +$2.29K |
|
808
Stanley Black & Decker
SWK
$11.9B
| $2.17K | ﹤0.01% |
32
-58
| -64% | -$3.93K |
|
|
CNR
809
Core Natural Resources, Inc.
CNR
$3.73B
| $2.09K | ﹤0.01% |
30
+4
| +15% | +$279 |
|
810
Paycom
PAYC
$12.5B
| $2.08K | ﹤0.01% |
9
-17
| -65% | -$3.94K |
|
811
Transocean
RIG
$2.96B
| $2.05K | ﹤0.01% |
+790
| New | +$2.05K |
|
812
Dayforce
DAY
$10.9B
| $1.99K | ﹤0.01% |
36
-47
| -57% | -$2.6K |
|
813
Corcept Therapeutics
CORT
$7.56B
| $1.98K | ﹤0.01% |
27
-19
| -41% | -$1.4K |
|
814
Booz Allen Hamilton
BAH
$12.7B
| $1.98K | ﹤0.01% |
19
-41
| -68% | -$4.27K |
|
|
BBUC
815
Brookfield Business Corp
BBUC
$2.33B
| $1.97K | ﹤0.01% |
+63
| New | +$1.97K |
|
816
CACI
CACI
$10.5B
| $1.91K | ﹤0.01% |
4
-10
| -71% | -$4.77K |
|
817
Avidity Biosciences
RNA
$6B
| $1.9K | ﹤0.01% |
+67
| New | +$1.9K |
|
818
Regal Rexnord
RRX
$9.45B
| $1.88K | ﹤0.01% |
13
-29
| -69% | -$4.2K |
|
819
TG Therapeutics
TGTX
$5.08B
| $1.8K | ﹤0.01% |
50
-23,967
| -100% | -$863K |
|
820
Halozyme
HALO
$8.9B
| $1.77K | ﹤0.01% |
+34
| New | +$1.77K |
|
821
Tetra Tech
TTEK
$9.22B
| $1.76K | ﹤0.01% |
+49
| New | +$1.76K |
|
822
ATI
ATI
$10.3B
| $1.73K | ﹤0.01% |
20
-31
| -61% | -$2.68K |
|
823
Chart Industries
GTLS
$8.96B
| $1.65K | ﹤0.01% |
10
-18
| -64% | -$2.97K |
|
824
FTAI Aviation
FTAI
$17B
| $1.61K | ﹤0.01% |
14
-25
| -64% | -$2.88K |
|
825
Uranium Energy
UEC
$5.37B
| $1.53K | ﹤0.01% |
225
-15
| -6% | -$102 |
|